DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 203 filers reported holding DENALI THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $359 | -37.5% | 17,381 | -30.2% | 0.00% | -40.0% |
Q1 2023 | $574 | -99.9% | 24,907 | +6.3% | 0.01% | -44.4% |
Q3 2022 | $719,000 | -61.9% | 23,434 | -63.5% | 0.01% | -60.9% |
Q2 2022 | $1,889,000 | +14.9% | 64,187 | +206.3% | 0.02% | +27.8% |
Q2 2021 | $1,644,000 | +702.0% | 20,959 | +266.2% | 0.02% | +350.0% |
Q3 2020 | $205,000 | -45.8% | 5,723 | -63.4% | 0.00% | -60.0% |
Q2 2020 | $378,000 | +147.1% | 15,637 | +56.4% | 0.01% | +100.0% |
Q3 2019 | $153,000 | -52.2% | 10,000 | -27.4% | 0.01% | -79.2% |
Q1 2019 | $320,000 | – | 13,770 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 19,462,500 | $404,042,000 | 54.41% |
Bratton Capital Management, L.P. | 953,035 | $19,785,000 | 29.05% |
Flagship Pioneering Inc. | 8,005,747 | $166,199,000 | 7.19% |
Casdin Capital, LLC | 400,000 | $8,304,000,000 | 0.78% |
Temasek Holdings (Private) Ltd | 4,410,457 | $91,561,000 | 0.65% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 22,595 | $469,000 | 0.37% |
MARK ASSET MANAGEMENT LP | 70,532 | $1,464,000 | 0.34% |
Artal Group S.A. | 400,000 | $8,304,000 | 0.34% |
PIER 88 INVESTMENT PARTNERS LLC | 27,650 | $574,000 | 0.24% |
WASATCH ADVISORS LP | 996,147 | $20,680,000 | 0.20% |